However, the preclinical evidence suggests that CBD’s efficacy goes beyond elevated clobazam levels, likely involving the positive modulation of GABAARs and multimodal engagement of anticonvulsant pathways in DS [155]. The gene discussed is OPN1MW; the disease is Dravet syndrome.